[HTML][HTML] The IARC perspective on cervical cancer screening

V Bouvard, N Wentzensen, A Mackie… - … England Journal of …, 2021 - Mass Medical Soc
Screening for Cervical Cancer This article reviews recent evidence from the International
Agency for Research on Cancer on the best methods of screening for cervical cancer …

Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force

J Melnikow, JT Henderson, BU Burda, CA Senger… - Jama, 2018 - jamanetwork.com
Importance Cervical cancer can be prevented with detection and treatment of precancerous
cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the …

Screening for cervical cancer: US Preventive Services Task Force recommendation statement

SJ Curry, AH Krist, DK Owens, MJ Barry, AB Caughey… - Jama, 2018 - jamanetwork.com
Importance The number of deaths from cervical cancer in the United States has decreased
substantially since the implementation of widespread cervical cancer screening and has …

Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology …

SJ Walters, IB dos Anjos Henriques-Cadby… - BMJ open, 2017 - bmjopen.bmj.com
Background Substantial amounts of public funds are invested in health research worldwide.
Publicly funded randomised controlled trials (RCTs) often recruit participants at a slower …

Screening for cervical cancer: US Preventive Services Task Force recommendation statement

VA Moyer… - Annals of internal …, 2012 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Description: Update of the 2003 US Preventive Services Task Force (USPSTF) …

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

J Bonde, A Floore, D Ejegod, FJ Vink… - … journal of cancer, 2021 - Wiley Online Library
In human papillomavirus (HPV) cervical cancer screening, cytology is used as triage to
counter the low specificity of HPV testing. VALID‐SCREEN is a EU‐multicenter …

Human papillomavirus laboratory testing: the changing paradigm

EM Burd - Clinical microbiology reviews, 2016 - Am Soc Microbiol
High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Primary cervical screening with high risk human papillomavirus testing: observational study

M Rebolj, J Rimmer, K Denton, J Tidy, C Mathews… - bmj, 2019 - bmj.com
Objective To provide the first report on the main outcomes from the prevalence and
incidence rounds of a large pilot of routine primary high risk human papillomavirus (hrHPV) …

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial

HC Kitchener, C Gilham, A Sargent, A Bailey… - European journal of …, 2011 - Elsevier
BACKGROUND: The additional sensitivity of HPV testing compared with cytology could
permit extended cervical screening intervals. We wished to determine, through a further …

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study

A Szarewski, D Mesher, L Cadman… - Journal of clinical …, 2012 - Am Soc Microbiol
High-risk human papillomavirus (HPV) DNA/RNA testing provides higher sensitivity but
lower specificity than cytology for the identification of high-grade cervical intraepithelial …